Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Regencell Bioscience Holdings Limited - Ordinary Shares (NQ:RGC)

5.285 -0.595 (-10.12%)
Streaming Delayed Price Updated: 12:23 PM EDT, Jul 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Regencell Bioscience Holdings Limited - Ordinary Shares

< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
News headline image
Kaplan Fox Encourages Investors of Regencell Bioscience Holdings Limited (NASDAQ: RGC) to Contact the Firm Before Lead Plaintiff Deadline on June 23, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Law Enforcement Lawsuit
News headline image
Regencell Bioscience Holdings Limited (RGC) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
From Law Offices of Howard G. Smith
Via Business Wire
News headline image
Kaplan Fox Alerts Regencell Bioscience Holdings Limited (RGC) Investors of June 23, 2026 Lead Plaintiff Deadline in Securities Class Action Case
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Law Enforcement Lawsuit
News headline image
Kaplan Fox Alerts Regencell Bioscience Holdings Limited (RGC) Investors of June 23, 2026 Lead Plaintiff Deadline in Securities Class Action Case
NEW YORK, NY - April 29, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Regencell Bioscience Holdings Limited (“Regencell” or the... 
Via TheNewswire.com
Topics Law Enforcement Lawsuit
RGC Stock Gains 20% Pre-Market — Retail Says Shorts Are In ‘Huge Trouble’ ↗
Via Stocktwits
News headline image
Securities Fraud Investigation Into Regencell Bioscience Holdings Limited (RGC) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
From The Law Offices of Frank R. Cruz
Via Business Wire
News headline image
Pomerantz Law Firm Announces the Filing of a Class Action Against Regencell Bioscience Holdings Limited and Certain Officers – RGC
From Pomerantz LLP
Via GlobeNewswire
News headline image
RGC Investors Have Opportunity to Lead Regencell Bioscience Holdings Limited Securities Fraud Lawsuit with the Schall Law Firm
From Schall Law
Via GlobeNewswire
News headline image
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Regencell Bioscience Holdings Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action – RGC
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
REGENCELL ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Regencell Bioscience Holdings Limited and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Rosen Law Firm Urges Regencell Bioscience Holdings Limited (NASDAQ: RGC) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
From The Rosen Law Firm, P.A.
Via Business Wire
News headline image
Investor Notice: Robbins LLP Informs Investors of the Regencell Bioscience Holdings Limited Class Action
From Robbins LLP
Via Business Wire
Keep an eye on the top gainers and losers in Wednesday's session. ↗
Via Chartmill
News headline image
Here's Why I Wouldn't Touch Regencell Bioscience With a 10‑Foot Pole Right Now ↗
Regencell Bioscience doesn't have a product yet, and there's no indication that one is on the way. 
Via The Motley Fool
News headline image
Don't Even Think About Buying Regencell Bioscience Stock Until You See This 1 Red Flag ↗
Regencell Bioscience is working on TCM opportunities, but what exactly is TCM? 
Via The Motley Fool
News headline image
Bragar Eagel & Squire, P.C. Continues Investigations into Regencell and Camping World on Behalf of Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Forget Regencell Bioscience: This Blue Chip Drug Maker Is the Boring Compounder You Need ↗
Don't follow general market sentiment when it comes to these two stocks. 
Via The Motley Fool
Top movers in Thursday's session ↗
Via Chartmill
Thursday's session: top gainers and losers ↗
Via Chartmill
Keep an eye on the top gainers and losers in Tuesday's session. ↗
Via Chartmill
These stocks are gapping in today's session ↗
Via Chartmill
News headline image
Bragar Eagel & Squire, P.C. Continues Investigations into Regencell and Camping World on Behalf of Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
These stocks are gapping in today's session ↗
Via Chartmill
Get insights into the top gainers and losers of Thursday's pre-market session. ↗
Via Chartmill
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
Via Chartmill
Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗
Via Chartmill
Let's take a look at the stocks that are in motion in today's session. ↗
Via Chartmill
Keep an eye on the top gainers and losers in Monday's session. ↗
Via Chartmill
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
Via Chartmill
News headline image
Regencell Bioscience (RGC) Stumbles into 2026: 8% Year-End Slide Sparks Technical Caution
As the final bells rang on the 2025 trading year, investors in Regencell Bioscience (NASDAQ: RGC) were met with a sobering reality check. The Hong Kong-based biotech firm, which has enjoyed a meteoric... 
Via MarketMinute
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.